静脉注射免疫球蛋白治疗儿童激素抵抗性腹型过敏性紫癜:值得开展对照试验
本文报告两例对高剂量静脉糖皮质激素抵抗的严重腹型过敏性紫癜(HScP)患儿,经静脉注射免疫球蛋白(IVIG)治疗后数日内完全恢复,并与文献中类似病例比较,认为IVIG可能有效,但需随机对照试验验证。
要点
- 两例激素抵抗性腹型HScP患儿经IVIG治疗后数日内完全恢复。
- IVIG可能作为儿童激素抵抗性HScP胃肠道血管炎的治疗选择。
- 尚需针对糖皮质激素的随机对照试验确认IVIG的真实疗效。
核心结论
- IVIG可能对儿童激素抵抗性HScP相关胃肠道血管炎有用,但需更结构化研究包括随机对照试验确认其真实有效性。
研究设计与样本
- 回顾性临床数据收集,并与现有文献比较。
主要发现
- 两例严重HScP胃肠道血管炎患儿对高剂量静脉糖皮质激素抵抗,经IVIG治疗后迅速起效并在数日内完全恢复。
- 两例患者的特征和对IVIG的反应与既往报告的其他病例相当。
临床怎么用
- 对于儿童严重腹型HScP且对高剂量静脉糖皮质激素抵抗者,可考虑使用IVIG。
局限性
- 仅为两例病例的回顾性观察,缺乏对照试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Henoch-Schönlein purpura (HScP) may present in children with severe, occasionally refractory, gastrointestinal (GI) involvement. The use of corticosteroids (CSs) is commonplace in the management of the disease, but to date no standardized protocol is available and, although rare, resistance to CS therapy may be challenging to clinicians. IVIG has been proposed as an effective alternative to CSs, but to date no controlled trial has been conducted to ascertain their real efficacy. We share our personal experience of successful IVIG treatment in two cases of GI HScP, comparing it with similar experiences reported in literature. METHODS: Retrospective clinical data collection, comparison with available literature. RESULTS: We describe two children with severe HScP GI vasculitis refractory to high-dose intravenous CSs that responded rapidly to IVIG administration, with complete recovery within a few days. Patient characteristics and response to IVIG administration were comparable to those of other previously reported cases. CONCLUSION: Our observation confirms that IVIG may be useful in the treatment of CS-resistant HScP-related GI vasculitis in children, and highlights the need for more structured research, including a randomized trial against CSs, in order to ascertain their real effectiveness.
引用
- Morotti F, Bracciolini G, Caorsi R, et al. Intravenous immunoglobulin for corticosteroid-resistant intestinal Henoch-Schönlein purpura: worth a controlled trial against corticosteroids? Rheumatology (Oxford). 2021. PMID: 34340243. doi:10.1093/rheumatology/keaa743
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。